Procalcitonin to guide antibiotic therapy in lower respiratory tract infections and sepsis

European Respiratory Disease

Volumn 8, Issue 1, 2012, Pages 71-74

  Weckermann, Renate ^a   Dinter, Christiane ^a   Wissmann, Christoph ^a  

^a Thermo Scientific BRAHMS Biomarkers ^*  (Germany)

Author keywords

Algorithms; Antibiotic guidance.; Assays; Bacterial resistance; Chronic obstructive pulmonary disease; Emergency department; Intensive care unit; Pneumonia; Primary care; Procalcitonin; Randomised clinical trials; Respiratory tract infection; Sepsis; Septic shock

Indexed keywords

EID: 84870048625     PISSN: 17545552     EISSN: 17545560     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Briel M, Schuetz P, Mueller B, et al., Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care, Arch Intern Med,2008;168(18):2000-7; discussion 2007-8.
2. Schuetz P, Christ-Crain M, Muller B, Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections - hope for hype?, Swiss Med Wkly,2009;139(23-4):318-26.
3. Schuetz P, Albrich W, Christ-Crain M, et al., Procalcitonin for guidance of antibiotic therapy, Expert Rev Anti Infect Ther,2010;8(5):575-87.
4. Becker KL, Nylen ES, White JC, et al., Clinical review 167:Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors, J Clin Endocrinol Metab,2004; 89(4):1512-25.
5. Morgenthaler NG, Struck J, Fischer-Schulz C, et al., Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA, Clin Lab,2002;48(5-6):263-70.
6. Meisner M, Procalcitonin - Biochemistry and Clinical Diagnosis, Bremen: UNI-MED, 2010.
7. Schuetz P, Chiappa V, Briel M, Greenwald JL, Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms, Arch Intern Med, 2011;171(15):1322-31.
8. Aabenhus R, Jensen JU, Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?, Prim Care Respir J, 2011;20(4):360-7.
9. Burkhardt O, Ewig S, Haagen U, et al., Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection, Eur Respir J, 2010;36(3):601-7.
10. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet, 2004;363(9409):600-7.
11. Christ-Crain M, Stolz D, Bingisser R, et al., Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial, Am J Respir Crit Care Med, 2006;174(1):84-93.
12. Stolz D, Christ-Crain M, Bingisser R, et al., Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy, Chest, 2007;131(1):9-19.
13. Long W, Deng XQ, Tang JG, et al., [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient], Zhonghua Nei Ke Za Zhi,2009;48(3):216-9.
14. Schuetz P, Christ-Crain M, Thomann R, et al., Effect of procalcitonin-based guidelines vs standard guidelines onantibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial, JAMA,2009;302(10):1059-66
15. Kristoffersen KB, Sogaard OS, Wejse C, et al., Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial, Clin Microbiol Infect,2009;15(5):481-7.
16. Svoboda P, Kantorova I, Scheer P, et al., Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepatogastroenterology,2007;54(74):359-63.
17. Nobre V, Harbarth S, Graf JD, et al., Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial, Am J Respir Crit Care Med, 2008;177(5):498-505.
18. Stolz D, Smyrnios N, Eggimann P, et al., Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia:a randomised study, Eur Respir J, 2009;34(6):1364-75.
19. Hochreiter M, Kohler T, Schweiger AM, et al., Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial, Crit Care,2009;13(3):R83.
20. Schroeder S, Hochreiter M, Koehler T, et al., Procalcitonin(PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study, Langenbecks Arch Surg, 2009;394(2):221-6.
21. Bouadma L, Luyt CE, Tubach F, et al., Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, Lancet, 2010;375(9713):463-74.
22. Stocker M, Fontana M, El Helou S, et al., Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis:prospective randomized intervention trial, Neonatology,2010;97(2):165-74.
23. Kopterides P, Siempos I, Tsangaris I, et al., Procalcitoninguided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials, Crit Care Med, 2010;38:2229-41.
24. Schuetz P, Batschwaroff M, Dusemund F, et al., Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey, Eur J Clin Microbiol Infect Dis,2010;29(3):269-77.
25. Harbarth S, Holeckova K, Froidevaux C, et al., Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis, Am J Respir Crit Care Med, 2001;164(3):396-402.
26. Brunkhorst FM, Heinz U, Forycki ZF, Kinetics of procalcitonin in iatrogenic sepsis, Intens Care Med,1998;24:888-92.
27. Dandona P, Nix D, Wilson MF, et al., Procalcitonin increase after endotoxin injection in normal subjects, J Clin Endocrinol Metab, 1994;79(6):1605-8.